title: Intercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endothelium.
abstract: OBJECTIVE
  Autoimmune inflammation of the retina causes vision loss in the majority of affected individuals. Th1 or Th17 cells initiate the disease on trafficking from the circulation into the eye across the retinal vascular endothelium. We investigated the ability of human Th1- and Th17-polarized cells to cross a simulated human retinal endothelium, and examined the role of IgG superfamily members in this process.
  
  
  METHODS
  Th1- and Th17-polarized cell populations were generated from human peripheral blood CD4(+) T cells, using two Th1- and Th17-polarizing protocols. Transendothelial migration assays were performed over 18 hours in Boyden chambers, after seeding the transwell membrane with human retinal endothelial cells. In some assays intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), or activated leukocyte cell adhesion molecule (ALCAM) blocking antibody, or isotype- and concentration-matched control antibody, was added to the upper chambers.
  
  
  RESULTS
  Th1- and Th17-polarized cells migrated equally efficiently across the human retinal endothelial monolayer. The percentage of IL-17(+) IFN-γ(-) Th17-polarized cells was reduced following migration. Blocking ICAM-1, but not VCAM-1 or ALCAM, significantly reduced migration of Th1- and Th17-polarized cells for a majority of human donors.
  
  
  CONCLUSIONS
  Taken in the context of other literature on transendothelial migration, our results illustrate the importance of investigating the specific tissue and vascular endothelium when considering helper T cell migration in autoimmune inflammation. Our findings further indicate that while generalizations about involvement of specific adhesion molecules in uveitis and other autoimmune disease may be possible, these may not apply to individual patients universally. The observations are relevant to the use of adhesion blockade for therapeutic purposes.
authors.affiliation: Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.
authors.forename: Arpita S
authors.initials: AS
authors.lastname: Bharadwaj
authors.forename: Lauren P
authors.initials: LP
authors.lastname: Schewitz-Bowers
authors.forename: Lai
authors.initials: L
authors.lastname: Wei
authors.forename: Richard W J
authors.initials: RW
authors.lastname: Lee
authors.forename: Justine R
authors.initials: JR
authors.lastname: Smith
mesh_terms: D020410:Activated-Leukocyte Cell Adhesion Molecule / Q000502:physiology; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D004730:Endothelium, Vascular / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000502:physiology*; D012171:Retinal Vessels; D018417:Th1 Cells / Q000378:metabolism / Q000502:physiology*; D058504:Th17 Cells / Q000378:metabolism / Q000502:physiology*; D057705:Transendothelial and Transepithelial Migration / Q000502:physiology*; D019010:Vascular Cell Adhesion Molecule-1 / Q000502:physiology
chemical_list: D020410:Activated-Leukocyte Cell Adhesion Molecule; D016207:Cytokines; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1
keywords: Th1 cell; Th17 cell; endothelial cell; retina; uveitis
references.citation: Lab Invest. 1992 Jul;67(1):42-55
references.pmid: 1625447
references.citation: Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5106-15
references.pmid: 17065532
references.citation: J Immunol. 2012 Aug 1;189(3):1220-7
references.pmid: 22745380
references.citation: J Immunol. 2011 Dec 1;187(11):5615-26
references.pmid: 22048764
references.citation: Semin Immunopathol. 2008 Apr;30(2):165-77
references.pmid: 18305941
references.citation: Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2676-84
references.pmid: 17525199
references.citation: Pharmacol Rev. 2005 Jun;57(2):173-85
references.pmid: 15914466
references.citation: Br J Ophthalmol. 2012 Feb;96(2):293-9
references.pmid: 22096139
references.citation: Arthritis Rheum. 2009 Jun;60(6):1647-56
references.pmid: 19479869
references.citation: Microvasc Res. 2003 Jan;65(1):18-23
references.pmid: 12535867
references.citation: Nat Med. 2007 Jun;13(6):711-8
references.pmid: 17496900
references.citation: Biochem Biophys Res Commun. 2002 May 3;293(2):710-3
references.pmid: 12054527
references.citation: Arch Ophthalmol. 1992 May;110(5):662-6
references.pmid: 1374609
references.citation: J Immunol. 2004 Mar 1;172(5):3215-24
references.pmid: 14978129
references.citation: Nat Immunol. 2011 Mar;12(3):255-63
references.pmid: 21278737
references.citation: J Immunol. 2011 Dec 15;187(12):6176-9
references.pmid: 22084440
references.citation: Clin Immunol Immunopathol. 1993 May;67(2):143-50
references.pmid: 8100190
references.citation: J Immunol. 2009 Dec 1;183(11):7169-77
references.pmid: 19890056
references.citation: Ann Neurol. 2009 Sep;66(3):390-402
references.pmid: 19810097
references.citation: Nat Med. 2007 Oct;13(10):1173-5
references.pmid: 17828272
references.citation: J Immunol. 2012 Feb 1;188(3):1421-30
references.pmid: 22219321
references.citation: Nat Immunol. 2008 Feb;9(2):137-45
references.pmid: 18157132
references.citation: Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3058-64
references.pmid: 18579762
references.citation: Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2891-6
references.pmid: 21282653
references.citation: J Immunol. 2004 Mar 1;172(5):2731-8
references.pmid: 14978070
references.citation: J Immunol. 2008 Sep 15;181(6):3750-4
references.pmid: 18768826
references.citation: J Exp Med. 2011 Nov 21;208(12):2465-76
references.pmid: 22025301
references.citation: J Immunol. 2008 Nov 15;181(10):7205-13
references.pmid: 18981142
references.citation: J Exp Med. 2008 Dec 22;205(13):3145-58
references.pmid: 19075290
references.citation: J Neuropathol Exp Neurol. 2001 Dec;60(12):1127-36
references.pmid: 11764086
references.citation: Nat Immunol. 2008 Jun;9(6):650-7
references.pmid: 18454150
references.citation: Methods Mol Biol. 2011;686:133-48
references.pmid: 21082369
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10623-8
references.pmid: 12963823
references.citation: J Lipid Res. 1997 Jan;38(1):147-59
references.pmid: 9034209
references.citation: Curr Eye Res. 1993 Oct;12(10):923-34
references.pmid: 8293668
references.citation: Exp Eye Res. 2012 Nov;104:89-93
references.pmid: 22940369
references.citation: J Immunol. 2010 Jul 1;185(1):679-87
references.pmid: 20511558
references.citation: J Immunol. 2008 May 15;180(10):6439-46
references.pmid: 18453558
references.citation: Br J Ophthalmol. 1996 Apr;80(4):332-6
references.pmid: 8703885
references.citation: J Immunol. 2008 Jun 1;180(11):7414-22
references.pmid: 18490741
references.citation: Br J Ophthalmol. 1996 Sep;80(9):844-8
references.pmid: 8962842
references.citation: Nat Rev Immunol. 2007 Sep;7(9):678-89
references.pmid: 17717539
references.citation: J Immunol. 2011 May 1;186(9):5021-3
references.pmid: 21505213
references.citation: Microvasc Res. 2001 Nov;62(3):236-42
references.pmid: 11678626
references.citation: Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3131-41
references.pmid: 1748544
references.citation: Lab Invest. 1994 Jan;70(1):39-52
references.pmid: 8302017
references.citation: Int Immunol. 2008 Nov;20(11):1361-8
references.pmid: 18820263
references.citation: J Exp Med. 2008 Aug 4;205(8):1903-16
references.pmid: 18663128
references.citation: Curr Eye Res. 2001 Apr;22(4):312-8
references.pmid: 11462171
references.citation: J Exp Med. 2008 Apr 14;205(4):799-810
references.pmid: 18391061
references.citation: J Leukoc Biol. 1998 Oct;64(4):434-40
references.pmid: 9766623
references.citation: Prog Retin Eye Res. 2013 Jan;32:102-80
references.pmid: 22982179
references.citation: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):226-34
references.pmid: 12506079
references.citation: Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2626-31
references.pmid: 7909311
references.citation: J Cell Biol. 2004 Oct 25;167(2):377-88
references.pmid: 15504916